Navigation Links
The impact of chronic diseases on patients also depends on their perception of the disease
Date:10/21/2010

This release is available in Spanish.

What do we mean by "common sense" when we talk about a disease? What affects the ideas and beliefs that patients have of their disease? Researchers at the University of Granada have developed a test for measuring and assessing chronic patients' cognitive representation of their disease. This advance will enable the development of clinical psychological treatments much more efficient than those currently employed.

The cognitive representation of a disease is the ideas and beliefs that patients have in relation to their condition, at a given time. These ideas are based around five aspects: symptoms, causes, impact of the disease on patients' lives, way and measures for controlling the condition, time-line and progression of the disease.

Cognitive representation is said to be based on "common sense", since patients are not experts and their ideas and perception of their disease are based on their own experience, self-knowledge and other sources (social, family environment, health center, etc). The researchers state that "the idea that patients have of their disease affects their own coping and adaptation to it".

This study was conducted by Macarena De los Santos Roig, at the department of Social Psychology and Methodology of Behavioral Sciences of the University of Granada, and led by professor Cristino Prez Melndez.

155 Patients

To carry out this study, the researchers used a sample of 155 patients with diabetes Type 1, treated at the Department of Endocronology of the University Hospital San Cecilio, Granada. Patients were given different tests and, although the study centered on patients with diabetes, this test is intended to be applicable to any patient with a chronic disease.

The study revealed that the profile of diabetic patients reporting many symptoms, with the perception of their disease having heavy impact on their lives, low perceived controllability, and a chronic course present significantly worse physical, psychological and social functioning, as well as a poor mental health, lower vitality and worse overall (physical) health, than those who represent their disease differently.

Conversely, patients face their disease more actively, (they seek social support, apply behavioral coping and express their emotions), when they perceive that their disease has significant impact on their lives, but some control is observed. Such results confirm the reliability of the scores obtained on the scale developed in this study. Thus, its effectiveness is demonstrated.

Although other similar assessment tools already existed in other countries, they had been deficiently translated (not adapted, and presenting some deficiencies) into Spanish by national researchers. Consequently, the tool developed by the University of Granada is the most complete and reliable of all existing assessment tools.


'/>"/>

Contact: Macarena De los Santos Roig
dlsantos@ugr.es
34-658-436-505
University of Granada
Source:Eurekalert

Related medicine news :

1. 2010 HSR Impact Award recognizes surgical safety research
2. New Research Examines Impact of Health Care Reform on Regional Health Plans
3. Local Blood Supply Impacted by Wednesdays Severe Snow Storm
4. Mayo Clinic responsible for $22 billion in economic impact, including $9.6 billion in Minnesota
5. Bersin & Associates Unveils Agenda for Research Conference, IMPACT 2010: The Business of Talent(R)
6. New research shows emotional impact of low sexual desire and associated distress
7. Pay-for-performance programs show positive impact on low-performing physicians
8. How health care is paid for appears to impact outcome
9. California to Examine Health Impacts of Landmark Cap-and-Trade Program
10. Small molecule with high impact
11. NxStage Announces New FREEDOM Data Showing the Positive Impact of its Daily Home Hemodialysis Therapy on Sleep Quality and Restless Legs Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... 27, 2016 , ... More than a third of American adults are considered ... surgery has received increased attention in recent years, as an article published ... weight loss, most people are familiar with the basic requirements of maintaining a healthy ...
(Date:5/27/2016)... ... ... With over 60 percent of acute stroke survivors being left unable to ... in the rehabilitation process has steadily increased. Ekso Bionics had been working to help ... stroke. , Ekso Bionics has now received clearance from the U.S. Food and Drug ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed ... by inspiring human interest stories, courtesy of leaders in the nursing and health ... the industry, from leading advocates and associations—namely Jones & Bartlett Learning. , Jones ...
(Date:5/26/2016)... ... ... There are many ways to cook a hot dog, but new research commissioned ... dogs straight off the grill. Of the 90 percent of Americans who say they ... hot dog, far outpacing other cooking methods such as steaming (12 percent), microwaving (9 ...
(Date:5/26/2016)... , ... May 26, 2016 , ... Connor Sports, ... basketball as a partner for the Tamika Catchings Legacy Tour that will ... industry leader in hardwood basketball surfaces in all forms and levels of the game, ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... MedDay, a biotechnology company focused on the treatment ... "High doses of biotin in progressive multiple sclerosis: extension phase ... Ayman Tourbah , Principal Investigator of the Phase 3 ... Neurology (EAN) in Copenhagen, Denmark . The ... on Sunday, 29 May 2016 from 14:45 to 16:15 CEST ...
(Date:5/24/2016)... --   , ... Endpunkte und demonstriert Ebenbürtigkeit bei der Gesamtreinigung des ... guter , Reinigung des ... (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a ) , ... der MORA-Studie der Phase III für NER1006 (1 ...
(Date:5/24/2016)... Celsion Corporation (NASDAQ: CLSN ... an update on its ongoing OVATION study, a ... the Company,s DNA-based immunotherapy, with the standard of ... advanced ovarian cancer who will undergo neoadjuvant chemotherapy ... IL-12 DNA plasmid vector formulated as a nanoparticle ...
Breaking Medicine Technology: